Last updated on January 2019

Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder


Brief description of study

The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.

Detailed Study Description

Study LVM-MD-11 is a randomized, double-blind, placebo- and active-controlled, parallel group, fixed-dose study in adolescent patients, ages 12-17 years. The study will be approximately 10 weeks in duration:

  • 1-week screening/washout period
  • 8-week double-blind treatment period
  • 1-week double-blind down-taper period

Patients who meet the eligibility criteria at Visit 2 (Baseline) will be randomized to 1 of 4 treatment groups: placebo, levomilnacipran 40 mg/day, levomilnacipran 80 mg/day, or fluoxetine 20 mg/day.

Clinical Study Identifier: NCT02431806

Find a site near you

Start Over

Noesis Pharma

Phoenix, AZ United States
  Connect »

Searcy Medical Center

Searcy, AR United States
  Connect »

Advanced Research Center

Anaheim, CA United States
  Connect »

CMB Clinical Trials

Colton, CA United States
  Connect »

ProScience Research Group

Culver City, CA United States
  Connect »

Sun Valley Research Center

Imperial, CA United States
  Connect »

Alliance for Research

Long Beach, CA United States
  Connect »

Renew Behavorial Health

Long Beach, CA United States
  Connect »

Asclepes Research Centers

Panorama City, CA United States
  Connect »

CITrials - Riverside

Riverside, CA United States
  Connect »

Langley Porter Psychiatric Institute

San Francisco, CA United States
  Connect »

Syrentis Clinical Research

Santa Ana, CA United States
  Connect »

MCB Clinical Research Center

Colorado Springs, CO United States
  Connect »

Coastal Clinical Research Specialists

Fernandina Beach, FL United States
  Connect »

Research in Miami Inc

Hialeah, FL United States
  Connect »

George M. Joseph MD, PA d.b.a. JosephCare

Jacksonville Beach, FL United States
  Connect »

Chicago SBMI Research Center

Panama City, FL United States
  Connect »

SCORE Physician Alliance, LLC

Saint Petersburg, FL United States
  Connect »

Clinical Research Institute

Stockbridge, GA United States
  Connect »

Capstone Clinical Research

Libertyville, IL United States
  Connect »

Sandeep Gaonkar, MD

Naperville, IL United States
  Connect »

Adams Clinical Trials, LLC

Watertown, MA United States
  Connect »

NeuroBehavioral Medicine Group

Bloomfield, MI United States
  Connect »

Mayo Clinic Depression Center

Rochester, MN United States
  Connect »

Kolade Research Institute

Las Vegas, NV United States
  Connect »

PRA Health Sciences

Marlton, NJ United States
  Connect »

Princeton Medical Institute

Princeton, NJ United States
  Connect »

Dent Neurologic Institute

Amherst, NY United States
  Connect »

Wake Forest Baptist Health

Winston-Salem, NC United States
  Connect »

Investigative Site 015

Garfield Heights, OH United States
  Connect »

IPS Research Company

Oklahoma City, OK United States
  Connect »

Sooner Clinical Research

Oklahoma City, OK United States
  Connect »

Cutting Edge Research Group

Oklahoma City, OK United States
  Connect »

Paradigm Research Professionals

Oklahoma City, OK United States
  Connect »

Cyn3rgy Research

Gresham, OR United States
  Connect »

Charleston Pediatrics

Charleston, SC United States
  Connect »

UTHSC-Houston

Houston, TX United States
  Connect »

Family Psychiatry of The Woodlands

The Woodlands, TX United States
  Connect »

UVA Child and Family Psychiatry Clinic

Charlottesville, VA United States
  Connect »

Clinical Research Partners, LLC

Petersburg, VA United States
  Connect »

Alliance Research Group

Richmond, VA United States
  Connect »

Carilion Medical Center

Roanoke, VA United States
  Connect »

Harmonex, Inc

Dothan, AL United States
  Connect »